For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For infants born to mothers with clinically apparent ...
Erythromycin (as base) 333mg, 500mg; del-rel tabs. Erythromycin acts by inhibition of protein synthesis by binding 50S ribosomal subunits of susceptible organisms. It does not affect nucleic acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results